Exchange: NASDAQ·Updated 05:00 PM EDT
CVKD logo

CVKD Cadrenal Therapeutics, Inc.

$1.35
$0.05
(3.76%)
Today
Closed $1.28
$0.07
(5.47%)
After Hours
Mkt Cap$4.74M
Vol167,414.00

About CVKD

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.
77

Extremely Bullish Sentiment

How do you feel about CVKD?

Advertisement|Remove ads.